HIPK

Homeodomain-interacting protein kinases (HIPKs) are evolutionarily conserved serine/threonine kinases that function as transcriptional regulators through interactions with homeobox proteins and other nuclear factors, thereby controlling cell survival, proliferation, differentiation, and apoptosis^[1][2]. Mechanistically, HIPK family members belong to the DYRK kinase branch and act primarily within the nucleus, where they regulate transcriptional programs rather than classical kinase cascades involving sequential cytoplasmic signaling events^[2]. HIPK proteins participate in developmental regulation and stress-responsive pathways, including Wnt signaling and p53-associated apoptotic control, linking transcriptional regulation to cellular fate decisions in experimental disease models^[2][3][4]. In cancer-related and stress-induced contexts, HIPK2 has been extensively studied for its ability to modulate p53-dependent transcriptional responses and apoptosis, establishing it as the most functionally characterized isoform within the family^[4][5]. Compared with HIPK1-3, HIPK4 displays distinct structural features despite conservation of the catalytic kinase domain, suggesting functional divergence within the HIPK subfamily^[1]. This distinction has supported the use of isoform-specific experimental models to investigate overlapping and unique biological functions among HIPK proteins^[1][2]. For experimental applications, recent studies have highlighted increasing interest in pharmacological HIPK inhibition, providing research tools for investigating developmental biology, transcriptional regulation, and disease-associated signaling mechanisms^[2].